Jake Keck Named VP Engineering & Service Operations at Tenacore LLC

June 26, 2020

Jake Keck has been named the new Vice President of Engineering & Service Operations at Tenacore, LLC. 

Jake Keck will lead the operations and quality teams in the implementation of a new service operating model and quality management system. Keck will serve as a member of the Tenacore executive leadership team reporting to CEO James Willett.

Keck’s team is responsible for daily service and repair operations, in addition to the quality function.  Jake’s team will be leading the company’s transition to a new service operations management platform, enabling Tenacore to reengineer current service and repair processes and transform service line capabilities. The transition to T-Connect will position Tenacore with best-in-class service and repair systems infrastructure, allowing customers to better manage asset repair costs.

“Jake is an outstanding addition to the Tenacore team, bringing a diverse base of experience in medical product design and operations leadership that will enable Tenacore to broaden and strengthen core service and repair capabilities,” says James Willett, CEO. Jake is the final addition to the new senior management team recruited to Tenacore to grow its focus in the service and repair of healthcare technology. Other senior leadership team members include Barbara Bitzer, CFO; Brandon Anaya, VP of Sales and Marketing; and Willett, the new CEO for Tenacore as of February 2020.

Keck most recently served as senior director of research and development with Vyaire Medical. He was responsible for new product development and design control of capital equipment. Jake has served as director of operations for Spectranetics (now Philips) Specialty & Drug-Coated Catheters where he led an operations team of over 60 for the launch of the company’s next-generation drug-coated catheter. He was responsible for launch planning, pipeline fill, capacity, resource, and contingency planning. Jake also held multiple research and development roles with Medtronic and Covidien.

“I am excited to join the leadership team at Tenacore and lead the operations and quality organizations as we expand the company into a leading force in the medical equipment service depot market,” said Keck. “This role provides an opportunity to apply a range of engineering and quality practices that are commonplace in the OEM market and make certain they are part of our standard operating practices at Tenacore. We want to ensure we are delivering for our customers and the patients they serve each day.”

Keck earned a BS in Mechanical Engineering Technology from Purdue University in West Lafayette, IN.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.